Skip to main content
. 2014 Sep 18;32(2):617–627. doi: 10.1007/s11095-014-1490-4

Fig. 1.

Fig. 1

Schematic representation of the structural model. Bronchodilatory effect on FEV1 is described by an Emax function using a KPD model as input for drug exposure. The overall response to treatment accounts for the course of disease, i.e., the natural decrease in FEV1 over time, which has been parameterised in terms of an indirect response model. See text for further explanation of the parameters.